The relation between apelin levels, echocardiographic findings and carotid intima media thickness in peritoneal dialysis patients

References

• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305
   PubMed Web of Science ®Google Scholar
• Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10(7):1606–1615
   PubMed Web of Science ®Google Scholar
• Knight EL, Rimm EB, Pai JK, et al. Kidney dysfunction, inflammation, and coronary events: A prospective study. J Am Soc Nephrol. 2004;15:1897–1903
   PubMed Web of Science ®Google Scholar
• Chandrasekaran B, Dar O, McDonagh T. The role of apelin in cardiovascular function and heart failure. Eur J Heart Fail. 2008;10:725–732
   PubMed Web of Science ®Google Scholar
• Małyszko J, Małyszko JS, Koźminski P, Myśliwiec M. Apelin and cardiac function in hemodialyzed patients: Possible relations. Am J Nephrol. 2006;26:121–126
   PubMed Web of Science ®Google Scholar
• Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr. 1980;33:27–39
   PubMed Web of Science ®Google Scholar
• Stein JH, Korcarz CE, Hurst RT, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111
   PubMed Web of Science ®Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation. 1978;58:1072–1083
   PubMed Web of Science ®Google Scholar
• Wang Y, Moss J, Thisted R. Predictors of body surface area. J Clin Anesth. 1992;4(1):4–10
   PubMedGoogle Scholar
• Reichek N, Devereux RB. Left ventricular hypertrophy: Relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation. 1981;63:1391–1398
   PubMed Web of Science ®Google Scholar
• Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int. 1996;49:1428–1434
   PubMed Web of Science ®Google Scholar
• Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol. 1987;59:956–960
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med. 1999;340:115–126
   PubMed Web of Science ®Google Scholar
• Best PJ, Holmes DR Jr. Chronic kidney disease as a cardiovascular risk factor. Am Heart J. 2003;145:383–386
   PubMed Web of Science ®Google Scholar
• El-Shehaby AM, El-Kathib MM, Battah AA, Roshdy AR. Apelin: A potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scand J Clin Lab Invest. 2010;70:421–427
   PubMed Web of Science ®Google Scholar
• Codognotto M, Piccoli A, Zaninotto M, et al. Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy. Am J Nephrol. 2007;27:1–6
   PubMed Web of Science ®Google Scholar
• Zhang DL, Liao H, Wei YY, Zhang Y, Zhang QD, Wang ZG. Elevation of serum apelin-13 is positively correlated with ADMA in patients on maintenance hemodialysis. Clin Nephrol. 2009;71:405–412
   PubMed Web of Science ®Google Scholar
• Leal VO, Lobo JC, Stockler-Pinto MB, et al. Apelin: A peptide involved in cardiovascular risk in hemodialysis patients? Ren Fail. 2012;34(5):577–581
   PubMed Web of Science ®Google Scholar
• Malyszko J, Malyszko JS, Mysliwiec M. Visfatin and endothelial function in dialyzed patients. Nephrology. 2010;15:190–196
   PubMed Web of Science ®Google Scholar
• Yavuz S, Cetinkaya S, Anarat A, Bayazıt AK. Apelin and nutritional status in children on dialysis. Ren Fail. 2014;14:1–6
   Google Scholar
• Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107:198–211
   PubMed Web of Science ®Google Scholar
• Wang M, Gupta RC, Rastogi S, et al. Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure. J Card Fail. 2013;19(7):509–516
   PubMed Web of Science ®Google Scholar
• Azizi M, Iturrioz X, Blanchard A, et al. Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol. 2008;19:1015–1024
   PubMed Web of Science ®Google Scholar
• Chen YC, Lin CJ, Wu CJ, Chen HH, Yeh JC. Comparison of extracellular volume and blood pressure in hemodialysis and peritoneal dialysis patients. Nephron Clin Pract. 2009;113(2):c112–c116
   PubMedGoogle Scholar
• Koç M, Toprak A, Tezcan H, Bihorac A, Akoğlu E, Özener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant. 2002;17:1661–1666
   PubMed Web of Science ®Google Scholar
• Karadag S, Ozturk S, Gursu M, et al. The relationship between apelin and cardiac parameters in patients on peritoneal dialysis: is there a new cardiac marker? BMC Nephrol. 2014;15(1):18
   PubMedGoogle Scholar
• Kazancioglu R, Gursu M, Karadag S, et al. Volume status in patients on peritoneal dialysis: the role of apelin and bio-impedance spectroscopy. Ren Fail. 2012;34(9):1068–1073
   PubMed Web of Science ®Google Scholar
• Daviaud D, Boucher J, Gesta S, et al. TNFα up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006;20:1528–1530
   PubMed Web of Science ®Google Scholar
• García-Díaz D, Campión J, Milagro FI, Martínez JA. Adiposity dependent apelin gene expression: Relationships with oxidative and inflammation markers. Mol Cell Biochem. 2007;305:87–94
   PubMed Web of Science ®Google Scholar
• Gotloib L, Waisbrut V, Shostak A, Kushnier R. Acute and long-term changes observed in imprints of mouse mesothelium exposed to glucose enriched, lactate buffered dialysis solution. Nephron. 1995;70:466–477
   PubMed Web of Science ®Google Scholar
• Hung WW, Hsieh TJ, Lin T, et al. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther. 2011;25:3–12
   PubMed Web of Science ®Google Scholar
• Malyszko J, Kozminski P, Malszko J, Mysliwiec M. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients. Int Urol Nephrol. 2011;43:185–190
   PubMed Web of Science ®Google Scholar
• Koken T, Serteser M, Kahraman A, Gokçe C, Demir S. Changes in serum markers of oxidative stress within various periods of hemodialysis. Nephrology. 2004;9:77–82
   PubMed Web of Science ®Google Scholar
• Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: An update. Clin Endocrinol (Oxf). 2006;64:355–365
   PubMed Web of Science ®Google Scholar
• Kadoglou NP, Sailer N, Kapelouzou A, et al. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes. Acta Diabetol. 2012;49(4):269–276
   PubMed Web of Science ®Google Scholar
• Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–1771
   PubMed Web of Science ®Google Scholar
• Bełtowski J. Apelin and visfatin: Unique “beneficial” adipokines upregulated in obesity? Med Sci Monit. 2006;12(6):112–119
   Web of Science ®Google Scholar